FDA says Philadelphia 7 sold unregistered, unlisted breast binders, making them misbranded devices.
What happened
FDA reviewed the firm’s website, passionalboutique.com, and found breast binders for sale, including the UNTAG line. FDA says the UNTAG manufacturer claims the binders help reduce gender dysphoria, making them devices. FDA’s records show the UNTAG binders were made in an unregistered establishment and were not listed, so FDA calls them misbranded.
What FDA found
The breast binders were made in an establishment that was not registered with FDA and the devices were not listed, so FDA calls them misbranded.
Section 510 of the Act (21 U.S.C. § 360); section 502(o) (21 U.S.C. § 352(o))The firm offered these misbranded devices for sale and introduction into interstate commerce, which is prohibited.
Section 301(a) of the Act (21 U.S.C. § 331(a))
What FDA wants
Respond in writing within 15 business days with the specific steps taken, corrective actions to prevent recurrence, documentation, and a timetable if work will continue; include reasoning if the firm believes the products are not in violation.
Who should pay attention
- online retailers selling health-related devices
- device manufacturers and importers that rely on establishment registration and listing
- brands buying devices from foreign manufacturers
This is a summary. Read the original letter on fda.gov.